Skip to main content
logo
Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
1.890
-0.090 (-4.55%)
At close: Sep 28, 2026, 4:00 PM EDT
1.950
+0.060 (3.17%)
Pre-market: Sep 29, 2026, 6:26 AM EDT

Regentis Biomaterials Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-13.02-13.654.8-4.13-1.45-5.14
Other Amortization
0.250.250.160.17--
Stock-Based Compensation
7.57.04----
Other Operating Activities
2.14.86-42.030.074.42
Change in Accounts Payable
-0.020.01-0.10.15-0.1-0.03
Change in Other Net Operating Assets
-0.650.12-1.50.56-0.020.88
Operating Cash Flow
-3.84-1.38-0.64-1.22-1.50.13
Operating Cash Flow Growth
------

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-0.30.40.33--
Long-Term Debt Issued
--0.45--1.24
Total Debt Issued
-0.30.850.33-1.24
Short-Term Debt Repaid
---0.33---
Total Debt Repaid
-1.2--0.33---
Net Debt Issued (Repaid)
-1.20.30.530.33-1.24
Issuance of Common Stock
13.848.22----
Financing Cash Flow
12.648.520.530.33-1.24

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
8.767.15-0.12-0.9-1.51.37

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
2.143.03-0.89-0.25-1.10.4
Unlevered Free Cash Flow
1.942.83-1.04-0.42-1.10.4

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-0.670.13-1.60.71-0.120.85
SEC Filings: 10-K · 10-Q